AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Press Release)
In the first clinical trial to directly compare gonadotropin releasing hormone (GnRH) antagonists, patients using Cetrotide (cetrorelix acetate for injection) required fewer injections compared to patients using ganirelix acetate (formerly known as Antagon Injection) to prevent premature ovulation during infertility treatment. The data were presented at the 60th Annual Meeting of the American Society for Reproductive Medicine (ASRM) by John G Wilcox, MD, FCOG, on 19 Oct 2004. The prospective, open-label, randomised, comparative study was conducted at 16 medical centres in the US and included 185 infertile patients…